Asosiy kontentga oʻtish
Maqola

Acute Serum VEGF as a Biomarker of Neurovascular Injury and Predictor of Cognitive Outcome After Ischemic Stroke: A Prospective Cohort Study

Elyor ТashkenovDepartment of Neurology, Andijan State Medical Institute, Andijan, UzbekistanG. RakhimbaevaDepartment of Neurology andMedical Psychology, Tashkent State Medical University, Farabi Street 2, Tashkent, 100109, UzbekistanUlugbek AbdukadirovDepartment of Neurology, Andijan State Medical Institute, Andijan, UzbekistanGulnoza UrinovaDepartment of Neurology, Andijan State Medical Institute, Andijan, UzbekistanI AbbosovaDepartment of Neurology, Andijan State Medical Institute, Andijan, UzbekistanArevik AbramyanDepartment of Neurology, Andijan State Medical Institute, Andijan, UzbekistanNigora KamalovaDepartment of Neurology, Andijan State Medical Institute, Andijan, Uzbekistan
2026en

Ochiq kirish: yoʻq

ABI

Annotatsiya

BACKGROUND: Post-Stroke Cognitive Impairment (PSCI) is a common consequence of ischemic stroke, but reliable early biomarkers remain limited. Vascular Endothelial Growth Factor (VEGF) is involved in angiogenesis and vascular permeability, yet its relationship with cognitive outcomes after stroke remains unclear. We investigated whether acute serum VEGF was associated with PSCI and functional outcome at three months. METHODS: This prospective cohort study included 119 patients with first-ever ischemic stroke. Serum VEGF was measured on day 5 using ELISA. Stroke severity was assessed using the NIHSS at admission, while cognition and functional outcome were evaluated at three months using the MoCA and modified Rankin Scale. Multivariable logistic regression and ROC analyses were performed. RESULTS: PSCI developed in 48 patients (40.3%). VEGF levels were significantly higher in patients with PSCI than in those without PSCI (786.68 ± 263.26 vs. 388.22 ± 159.87 pg/mL, p < 0.001). After multivariable adjustment, both NIHSS (OR = 1.446, 95% CI: 1.200-1.744) and VEGF (OR = 1.004 per pg/mL, 95% CI: 1.002-1.006) remained significantly associated with PSCI (both p < 0.001). ROC analysis yielded an AUC of 0.844, with a cut-off of 440.3 pg/mL providing 85.4% sensitivity and 78.9% specificity. VEGF was not independently associated with functional outcome after adjustment. DISCUSSION: Higher acute VEGF levels were associated with subsequent cognitive impairment. This may reflect the complex neurovascular response to ischemic injury, although the underlying mechanisms were not directly examined in this study. CONCLUSION: Elevated acute serum VEGF was significantly associated with PSCI at three months after ischemic stroke. These findings support further investigation of VEGF as a potential candidate biomarker of post-stroke cognitive outcome, requiring validation in independent cohorts.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba